by Shi-qi An | Oct 6, 2025 | News
Abselion article published in International Biopharmaceutical Industry (IBI) Autumn 2025 We are pleased to announce that Abselion’s article has been published in the Autumn 2025 issue of International Biopharmaceutical Industry (IBI). Co-authored by Professor Alan...
by Shi-qi An | Sep 30, 2025 | News
Abselion’s Protein G Kit Featured in Discover Pharma Discover Pharma has published coverage of Abselion’s latest product launch — the Protein G Total Antibody Quantification Kit for the Amperia™ platform. The article highlights how the new kit complements the existing...
by Shi-qi An | Sep 26, 2025 | News
Abselion & NHS Blood & Transplant Highly Commended at Cambridge Business Awards We are delighted to share that Abselion, together with NHS Blood & Transplant, was Highly Commended in The Award for Collaboration at the 2025 Cambridge Business Awards,...
by shannon@kinsdesign.co | Sep 5, 2025 | News
Abselion’s CEO, Dr. Ruizhi Wang, was recently featured in a BioCompare editorial article, “Cell-Based Gene Therapies: Challenges and Advances in Upstream Manufacturing.” The piece brings together perspectives from leaders across the field, highlighting the hurdles and...
by Shi-qi An | Aug 28, 2025 | News
Abselion is featured in Biocompare’s latest editorial on antibody libraries — indispensable tools for research and drug discovery. In this Q&A, Dr. Ruizhi Wang discusses how antibody libraries are shaping the future of therapeutic development, from enabling novel...
by Shi-qi An | Apr 24, 2025 | News
NHS Blood and Transplant Clinical Biotechnology Centre implements the Amperia™ system to streamline viral vector process development for novel gene therapies The NHSBT Clinical Biotechnology Centre (CBC), Bristol, one of three government selected Innovation Hubs...
